Tine M Hansen1,2, Dina Lelic3, Anne E Olesen2,3,4, Asbjørn Mohr Drewes2,3, Jens B Frøkjaer1,2. 1. Mech-Sense, Department of Radiology, Aalborg University Hospital, Aalborg, Denmark. 2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 3. Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark. 4. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
AIM: Different mechanisms may be involved in the antinociceptive effects of oxycodone (opioid) and venlafaxine (serotonin-norepinephrine reuptake inhibitor), and the aim of this study was to investigate the effect of these drugs on brain functional connectivity. METHODS: Resting state functional magnetic resonance imaging was acquired in 20 healthy volunteers before and after a 5-day treatment with oxycodone, venlafaxine, or placebo in a randomized, double-blind, crossover study. Functional connectivity analyses were performed between four predefined seeds (dorsal anterior cingulate cortex, rostral anterior cingulate cortex, posterior insula, and prefrontal cortex), and the whole brain. RESULTS: The overall interpretation was that there were differences between the effects of oxycodone and venlafaxine on functional connectivity. Oxycodone mainly showed decreased functional connectivity between limbic structures and to supralimbic areas (all P < 0.05). Venlafaxine also showed decreased functional connectivity between limbic structures and to supralimbic areas, but increased functional connectivity to structures in the midbrain and brain stem was also found (all P < 0.05). CONCLUSIONS:Oxycodone and venlafaxine showed differential effects on resting-state functional connectivity as compared to placebo. This supports that the two drugs exert different mechanisms, and that the drugs in combination may exert additive effects and could potentially improve pain therapy.
RCT Entities:
AIM: Different mechanisms may be involved in the antinociceptive effects of oxycodone (opioid) and venlafaxine (serotonin-norepinephrine reuptake inhibitor), and the aim of this study was to investigate the effect of these drugs on brain functional connectivity. METHODS: Resting state functional magnetic resonance imaging was acquired in 20 healthy volunteers before and after a 5-day treatment with oxycodone, venlafaxine, or placebo in a randomized, double-blind, crossover study. Functional connectivity analyses were performed between four predefined seeds (dorsal anterior cingulate cortex, rostral anterior cingulate cortex, posterior insula, and prefrontal cortex), and the whole brain. RESULTS: The overall interpretation was that there were differences between the effects of oxycodone and venlafaxine on functional connectivity. Oxycodone mainly showed decreased functional connectivity between limbic structures and to supralimbic areas (all P < 0.05). Venlafaxine also showed decreased functional connectivity between limbic structures and to supralimbic areas, but increased functional connectivity to structures in the midbrain and brain stem was also found (all P < 0.05). CONCLUSIONS:Oxycodone and venlafaxine showed differential effects on resting-state functional connectivity as compared to placebo. This supports that the two drugs exert different mechanisms, and that the drugs in combination may exert additive effects and could potentially improve pain therapy.
Authors: Alexander Schaefer; Inga Burmann; Ralf Regenthal; Katrin Arélin; Claudia Barth; André Pampel; Arno Villringer; Daniel S Margulies; Julia Sacher Journal: Curr Biol Date: 2014-09-18 Impact factor: 10.834
Authors: Eric Ichesco; Andres Quintero; Daniel J Clauw; Scott Peltier; Pia M Sundgren; Geoffrey E Gerstner; Tobias Schmidt-Wilcke Journal: Headache Date: 2011-09-19 Impact factor: 5.887
Authors: Ulf Baumgärtner; Hans-Georg Buchholz; Alexander Bellosevich; Walter Magerl; Thomas Siessmeier; Roman Rolke; Sabine Höhnemann; Markus Piel; Frank Rösch; Hans-Jürgen Wester; Gjermund Henriksen; Peter Stoeter; Peter Bartenstein; Rolf-Detlef Treede; Mathias Schreckenberger Journal: Neuroimage Date: 2005-12-07 Impact factor: 6.556
Authors: Jon-Kar Zubieta; Joshua A Bueller; Lisa R Jackson; David J Scott; Yanjun Xu; Robert A Koeppe; Thomas E Nichols; Christian S Stohler Journal: J Neurosci Date: 2005-08-24 Impact factor: 6.167
Authors: Maija L Haanpää; Geoffrey K Gourlay; Joel L Kent; Christine Miaskowski; Srinivasa N Raja; Kenneth E Schmader; Christopher D Wells Journal: Mayo Clin Proc Date: 2010-03 Impact factor: 7.616
Authors: A K Jones; S K Luthra; B Maziere; V W Pike; C Loc'h; C Crouzel; A Syrota; T Jones Journal: J Neurosci Methods Date: 1988-03 Impact factor: 2.390
Authors: Tine M Hansen; Dina Lelic; Anne E Olesen; Asbjørn Mohr Drewes; Jens B Frøkjaer Journal: CNS Neurosci Ther Date: 2018-02-21 Impact factor: 5.243
Authors: Cherkaouia Kibaly; Jacob A Alderete; Steven H Liu; Hazem S Nasef; Ping-Yee Law; Christopher J Evans; Catherine M Cahill Journal: Cell Mol Neurobiol Date: 2020-11-27 Impact factor: 4.231